The combined use of sevoflurane and nalbuphine hydrochloride for for chidren undergoing enteroscopy

The effect of nalbuphine hydrochloride on the MAC value of sevoflurane in children undergoing enteroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017009

Enrollment

Unknown

Registered

2018-07-07

Start date

2018-07-16

Completion date

Unknown

Last updated

2018-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric enteroscopy

Interventions

Group nalbuphine:injected with naborphine 0.2mg/kg 5 minutes before anesthesia

Group S:injected with normal saline 10ml before anesthesia

Eligibility

Sex/Gender

All

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 100 ASA physical status I or II patients aged 3-12 years, who are scheduling for enteroscopy with general anesthesia.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had a history of Cardiopulmonary dysfunction,had a history of acute airway inflammation in the previous 2 weeks, neuromuscular disease, a possible or confirmed difficult airway, a suspected history of abuse of narcotic analgesics or sedatives, a history of allergy to propofol or opioids. Family members refuse to attend.

Design outcomes

Primary

Measure	Time frame
sevoflurane concentration;The recovery time;complications;postoperative VAS pain score;OAAS consciousness score;	—

Countries

China

Contacts

Public ContactXingrong Song

Department of Anesthesiology, Guangzhou Women and Children's Medical Center

sxjess@126.com+86 13922416303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026